IBD: 组织学累积炎症模型可预测溃疡性结肠炎患者结肠肿瘤形成的风险

2021-01-20 网络 网络

溃疡性结肠炎(UC)中的慢性炎症与结肠肿瘤形成(CRN)有关。最近美国一个医疗小组发明了一种新的累积炎症指数,该指数可以预测UC患者中CRN的发生概率。

背景及目的:

溃疡性结肠炎(UC)中的慢性炎症与结肠肿瘤形成(CRN)有关。最近美国一个医疗小组发明了一种新的累积炎症指数,该指数可以预测UC患者中CRN的发生概率,因此,本项研究通过在芝加哥大学医疗中心展开独立,匹配的病例对照的队列研究对这一模型进行验证。

 

 

方法

芝加哥大学的研究人员通过将每个组织炎性活动(HIA)得分相加,然后乘以监视间隔的长度,可以计算出累积的炎性负担(CIB)。持续性是指监视次数(严重性得分> 2)除以监视次数总数。T检验比较了平均分和最高HIA评分,并评估了平均分和最高严重程度,CIB和持久性之间的相关性。

 

 

结果

本项研究共分析了62例UC患者(26例CRN患者,36例无CRN对照患者)。55%为男性,平均病程为20.6岁,CRN诊断的平均年龄为43.9岁。在CRN患者中,有6名(23%)患有结肠癌,有16名(62%)患有低度不典型增生,而4名(15%)患有不确定性增生。使用平均HIA分数,研究人员发现CRN患者的CIB在统计学上更高(P = 0.04)。使用最高HIA评分,研究人员发现CRN患者的CIB(P = 0.02),平均严重程度(P = 0.03)和持续性(P = 0.01)明显更高。

 

 

 

结论

UC患者的累积组织学炎症评分与CRN的发展显着相关。这表明控制炎症可以降低CRN风险。

 

 

原始出处:

Olivia V Yvellez. Et al. Cumulative Histologic Inflammation Predicts Colorectal Neoplasia in Ulcerative Colitis: A Validation Study. Inflammatory Bowel Diseases.2021.

 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1926285, encodeId=d4b1192628538, content=<a href='/topic/show?id=9238e767680' target=_blank style='color:#2F92EE;'>#组织学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77676, encryptionId=9238e767680, topicName=组织学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Mon Jul 26 11:29:56 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677482, encodeId=427d16e7482b3, content=<a href='/topic/show?id=98fee879281' target=_blank style='color:#2F92EE;'>#结肠肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78792, encryptionId=98fee879281, topicName=结肠肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bae427519118, createdName=chenlianhui, createdTime=Tue May 04 09:29:56 CST 2021, time=2021-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809087, encodeId=3145180908ee4, content=<a href='/topic/show?id=f0f982912b0' target=_blank style='color:#2F92EE;'>#肿瘤形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82912, encryptionId=f0f982912b0, topicName=肿瘤形成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Sat Aug 28 07:29:56 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1695218, encodeId=b2dd169521870, content=<a href='/topic/show?id=c76e6645438' target=_blank style='color:#2F92EE;'>#溃疡性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66454, encryptionId=c76e6645438, topicName=溃疡性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787129789891, createdName=nymo, createdTime=Fri Jun 18 15:29:56 CST 2021, time=2021-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954932, encodeId=f811954932db, content=已看,还可以。, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 16:17:49 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263628, encodeId=3201126362846, content=<a href='/topic/show?id=75bc930217' target=_blank style='color:#2F92EE;'>#IBD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9302, encryptionId=75bc930217, topicName=IBD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Fri Jan 22 11:29:56 CST 2021, time=2021-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047878, encodeId=a452104e8783c, content=梅斯里提供了很多疾病的模型计算公式,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Wed Jan 20 23:29:56 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918507, encodeId=7d8791850e25, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210518/cd5ae48bc99d4e5b99357ba20b7ae160/700da5bab6de47cba94dcc7b36f23639.jpg, createdBy=f1831296933, createdName=ltxdsr810920, createdTime=Wed Jan 20 20:37:01 CST 2021, time=2021-01-20, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1926285, encodeId=d4b1192628538, content=<a href='/topic/show?id=9238e767680' target=_blank style='color:#2F92EE;'>#组织学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77676, encryptionId=9238e767680, topicName=组织学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Mon Jul 26 11:29:56 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677482, encodeId=427d16e7482b3, content=<a href='/topic/show?id=98fee879281' target=_blank style='color:#2F92EE;'>#结肠肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78792, encryptionId=98fee879281, topicName=结肠肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bae427519118, createdName=chenlianhui, createdTime=Tue May 04 09:29:56 CST 2021, time=2021-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809087, encodeId=3145180908ee4, content=<a href='/topic/show?id=f0f982912b0' target=_blank style='color:#2F92EE;'>#肿瘤形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82912, encryptionId=f0f982912b0, topicName=肿瘤形成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Sat Aug 28 07:29:56 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1695218, encodeId=b2dd169521870, content=<a href='/topic/show?id=c76e6645438' target=_blank style='color:#2F92EE;'>#溃疡性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66454, encryptionId=c76e6645438, topicName=溃疡性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787129789891, createdName=nymo, createdTime=Fri Jun 18 15:29:56 CST 2021, time=2021-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954932, encodeId=f811954932db, content=已看,还可以。, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 16:17:49 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263628, encodeId=3201126362846, content=<a href='/topic/show?id=75bc930217' target=_blank style='color:#2F92EE;'>#IBD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9302, encryptionId=75bc930217, topicName=IBD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Fri Jan 22 11:29:56 CST 2021, time=2021-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047878, encodeId=a452104e8783c, content=梅斯里提供了很多疾病的模型计算公式,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Wed Jan 20 23:29:56 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918507, encodeId=7d8791850e25, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210518/cd5ae48bc99d4e5b99357ba20b7ae160/700da5bab6de47cba94dcc7b36f23639.jpg, createdBy=f1831296933, createdName=ltxdsr810920, createdTime=Wed Jan 20 20:37:01 CST 2021, time=2021-01-20, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1926285, encodeId=d4b1192628538, content=<a href='/topic/show?id=9238e767680' target=_blank style='color:#2F92EE;'>#组织学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77676, encryptionId=9238e767680, topicName=组织学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Mon Jul 26 11:29:56 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677482, encodeId=427d16e7482b3, content=<a href='/topic/show?id=98fee879281' target=_blank style='color:#2F92EE;'>#结肠肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78792, encryptionId=98fee879281, topicName=结肠肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bae427519118, createdName=chenlianhui, createdTime=Tue May 04 09:29:56 CST 2021, time=2021-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809087, encodeId=3145180908ee4, content=<a href='/topic/show?id=f0f982912b0' target=_blank style='color:#2F92EE;'>#肿瘤形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82912, encryptionId=f0f982912b0, topicName=肿瘤形成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Sat Aug 28 07:29:56 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1695218, encodeId=b2dd169521870, content=<a href='/topic/show?id=c76e6645438' target=_blank style='color:#2F92EE;'>#溃疡性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66454, encryptionId=c76e6645438, topicName=溃疡性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787129789891, createdName=nymo, createdTime=Fri Jun 18 15:29:56 CST 2021, time=2021-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954932, encodeId=f811954932db, content=已看,还可以。, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 16:17:49 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263628, encodeId=3201126362846, content=<a href='/topic/show?id=75bc930217' target=_blank style='color:#2F92EE;'>#IBD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9302, encryptionId=75bc930217, topicName=IBD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Fri Jan 22 11:29:56 CST 2021, time=2021-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047878, encodeId=a452104e8783c, content=梅斯里提供了很多疾病的模型计算公式,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Wed Jan 20 23:29:56 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918507, encodeId=7d8791850e25, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210518/cd5ae48bc99d4e5b99357ba20b7ae160/700da5bab6de47cba94dcc7b36f23639.jpg, createdBy=f1831296933, createdName=ltxdsr810920, createdTime=Wed Jan 20 20:37:01 CST 2021, time=2021-01-20, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1926285, encodeId=d4b1192628538, content=<a href='/topic/show?id=9238e767680' target=_blank style='color:#2F92EE;'>#组织学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77676, encryptionId=9238e767680, topicName=组织学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Mon Jul 26 11:29:56 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677482, encodeId=427d16e7482b3, content=<a href='/topic/show?id=98fee879281' target=_blank style='color:#2F92EE;'>#结肠肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78792, encryptionId=98fee879281, topicName=结肠肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bae427519118, createdName=chenlianhui, createdTime=Tue May 04 09:29:56 CST 2021, time=2021-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809087, encodeId=3145180908ee4, content=<a href='/topic/show?id=f0f982912b0' target=_blank style='color:#2F92EE;'>#肿瘤形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82912, encryptionId=f0f982912b0, topicName=肿瘤形成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Sat Aug 28 07:29:56 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1695218, encodeId=b2dd169521870, content=<a href='/topic/show?id=c76e6645438' target=_blank style='color:#2F92EE;'>#溃疡性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66454, encryptionId=c76e6645438, topicName=溃疡性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787129789891, createdName=nymo, createdTime=Fri Jun 18 15:29:56 CST 2021, time=2021-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954932, encodeId=f811954932db, content=已看,还可以。, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 16:17:49 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263628, encodeId=3201126362846, content=<a href='/topic/show?id=75bc930217' target=_blank style='color:#2F92EE;'>#IBD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9302, encryptionId=75bc930217, topicName=IBD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Fri Jan 22 11:29:56 CST 2021, time=2021-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047878, encodeId=a452104e8783c, content=梅斯里提供了很多疾病的模型计算公式,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Wed Jan 20 23:29:56 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918507, encodeId=7d8791850e25, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210518/cd5ae48bc99d4e5b99357ba20b7ae160/700da5bab6de47cba94dcc7b36f23639.jpg, createdBy=f1831296933, createdName=ltxdsr810920, createdTime=Wed Jan 20 20:37:01 CST 2021, time=2021-01-20, status=1, ipAttribution=)]
    2021-06-18 nymo
  5. [GetPortalCommentsPageByObjectIdResponse(id=1926285, encodeId=d4b1192628538, content=<a href='/topic/show?id=9238e767680' target=_blank style='color:#2F92EE;'>#组织学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77676, encryptionId=9238e767680, topicName=组织学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Mon Jul 26 11:29:56 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677482, encodeId=427d16e7482b3, content=<a href='/topic/show?id=98fee879281' target=_blank style='color:#2F92EE;'>#结肠肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78792, encryptionId=98fee879281, topicName=结肠肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bae427519118, createdName=chenlianhui, createdTime=Tue May 04 09:29:56 CST 2021, time=2021-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809087, encodeId=3145180908ee4, content=<a href='/topic/show?id=f0f982912b0' target=_blank style='color:#2F92EE;'>#肿瘤形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82912, encryptionId=f0f982912b0, topicName=肿瘤形成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Sat Aug 28 07:29:56 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1695218, encodeId=b2dd169521870, content=<a href='/topic/show?id=c76e6645438' target=_blank style='color:#2F92EE;'>#溃疡性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66454, encryptionId=c76e6645438, topicName=溃疡性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787129789891, createdName=nymo, createdTime=Fri Jun 18 15:29:56 CST 2021, time=2021-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954932, encodeId=f811954932db, content=已看,还可以。, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 16:17:49 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263628, encodeId=3201126362846, content=<a href='/topic/show?id=75bc930217' target=_blank style='color:#2F92EE;'>#IBD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9302, encryptionId=75bc930217, topicName=IBD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Fri Jan 22 11:29:56 CST 2021, time=2021-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047878, encodeId=a452104e8783c, content=梅斯里提供了很多疾病的模型计算公式,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Wed Jan 20 23:29:56 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918507, encodeId=7d8791850e25, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210518/cd5ae48bc99d4e5b99357ba20b7ae160/700da5bab6de47cba94dcc7b36f23639.jpg, createdBy=f1831296933, createdName=ltxdsr810920, createdTime=Wed Jan 20 20:37:01 CST 2021, time=2021-01-20, status=1, ipAttribution=)]
    2021-04-07 ms6000001015893838

    已看,还可以。

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1926285, encodeId=d4b1192628538, content=<a href='/topic/show?id=9238e767680' target=_blank style='color:#2F92EE;'>#组织学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77676, encryptionId=9238e767680, topicName=组织学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Mon Jul 26 11:29:56 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677482, encodeId=427d16e7482b3, content=<a href='/topic/show?id=98fee879281' target=_blank style='color:#2F92EE;'>#结肠肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78792, encryptionId=98fee879281, topicName=结肠肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bae427519118, createdName=chenlianhui, createdTime=Tue May 04 09:29:56 CST 2021, time=2021-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809087, encodeId=3145180908ee4, content=<a href='/topic/show?id=f0f982912b0' target=_blank style='color:#2F92EE;'>#肿瘤形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82912, encryptionId=f0f982912b0, topicName=肿瘤形成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Sat Aug 28 07:29:56 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1695218, encodeId=b2dd169521870, content=<a href='/topic/show?id=c76e6645438' target=_blank style='color:#2F92EE;'>#溃疡性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66454, encryptionId=c76e6645438, topicName=溃疡性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787129789891, createdName=nymo, createdTime=Fri Jun 18 15:29:56 CST 2021, time=2021-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954932, encodeId=f811954932db, content=已看,还可以。, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 16:17:49 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263628, encodeId=3201126362846, content=<a href='/topic/show?id=75bc930217' target=_blank style='color:#2F92EE;'>#IBD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9302, encryptionId=75bc930217, topicName=IBD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Fri Jan 22 11:29:56 CST 2021, time=2021-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047878, encodeId=a452104e8783c, content=梅斯里提供了很多疾病的模型计算公式,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Wed Jan 20 23:29:56 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918507, encodeId=7d8791850e25, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210518/cd5ae48bc99d4e5b99357ba20b7ae160/700da5bab6de47cba94dcc7b36f23639.jpg, createdBy=f1831296933, createdName=ltxdsr810920, createdTime=Wed Jan 20 20:37:01 CST 2021, time=2021-01-20, status=1, ipAttribution=)]
    2021-01-22 bnurmamat
  7. [GetPortalCommentsPageByObjectIdResponse(id=1926285, encodeId=d4b1192628538, content=<a href='/topic/show?id=9238e767680' target=_blank style='color:#2F92EE;'>#组织学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77676, encryptionId=9238e767680, topicName=组织学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Mon Jul 26 11:29:56 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677482, encodeId=427d16e7482b3, content=<a href='/topic/show?id=98fee879281' target=_blank style='color:#2F92EE;'>#结肠肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78792, encryptionId=98fee879281, topicName=结肠肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bae427519118, createdName=chenlianhui, createdTime=Tue May 04 09:29:56 CST 2021, time=2021-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809087, encodeId=3145180908ee4, content=<a href='/topic/show?id=f0f982912b0' target=_blank style='color:#2F92EE;'>#肿瘤形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82912, encryptionId=f0f982912b0, topicName=肿瘤形成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Sat Aug 28 07:29:56 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1695218, encodeId=b2dd169521870, content=<a href='/topic/show?id=c76e6645438' target=_blank style='color:#2F92EE;'>#溃疡性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66454, encryptionId=c76e6645438, topicName=溃疡性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787129789891, createdName=nymo, createdTime=Fri Jun 18 15:29:56 CST 2021, time=2021-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954932, encodeId=f811954932db, content=已看,还可以。, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 16:17:49 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263628, encodeId=3201126362846, content=<a href='/topic/show?id=75bc930217' target=_blank style='color:#2F92EE;'>#IBD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9302, encryptionId=75bc930217, topicName=IBD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Fri Jan 22 11:29:56 CST 2021, time=2021-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047878, encodeId=a452104e8783c, content=梅斯里提供了很多疾病的模型计算公式,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Wed Jan 20 23:29:56 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918507, encodeId=7d8791850e25, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210518/cd5ae48bc99d4e5b99357ba20b7ae160/700da5bab6de47cba94dcc7b36f23639.jpg, createdBy=f1831296933, createdName=ltxdsr810920, createdTime=Wed Jan 20 20:37:01 CST 2021, time=2021-01-20, status=1, ipAttribution=)]
    2021-01-20 CHANGE

    梅斯里提供了很多疾病的模型计算公式,赞一个!

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=1926285, encodeId=d4b1192628538, content=<a href='/topic/show?id=9238e767680' target=_blank style='color:#2F92EE;'>#组织学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77676, encryptionId=9238e767680, topicName=组织学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Mon Jul 26 11:29:56 CST 2021, time=2021-07-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677482, encodeId=427d16e7482b3, content=<a href='/topic/show?id=98fee879281' target=_blank style='color:#2F92EE;'>#结肠肿瘤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78792, encryptionId=98fee879281, topicName=结肠肿瘤)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bae427519118, createdName=chenlianhui, createdTime=Tue May 04 09:29:56 CST 2021, time=2021-05-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1809087, encodeId=3145180908ee4, content=<a href='/topic/show?id=f0f982912b0' target=_blank style='color:#2F92EE;'>#肿瘤形成#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=82912, encryptionId=f0f982912b0, topicName=肿瘤形成)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05a2499, createdName=dzx0922889, createdTime=Sat Aug 28 07:29:56 CST 2021, time=2021-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1695218, encodeId=b2dd169521870, content=<a href='/topic/show?id=c76e6645438' target=_blank style='color:#2F92EE;'>#溃疡性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=66454, encryptionId=c76e6645438, topicName=溃疡性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=787129789891, createdName=nymo, createdTime=Fri Jun 18 15:29:56 CST 2021, time=2021-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=954932, encodeId=f811954932db, content=已看,还可以。, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1bc65476534, createdName=ms6000001015893838, createdTime=Wed Apr 07 16:17:49 CST 2021, time=2021-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263628, encodeId=3201126362846, content=<a href='/topic/show?id=75bc930217' target=_blank style='color:#2F92EE;'>#IBD#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=9302, encryptionId=75bc930217, topicName=IBD)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fc0372, createdName=bnurmamat, createdTime=Fri Jan 22 11:29:56 CST 2021, time=2021-01-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1047878, encodeId=a452104e8783c, content=梅斯里提供了很多疾病的模型计算公式,赞一个!, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=CHANGE, createdTime=Wed Jan 20 23:29:56 CST 2021, time=2021-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=918507, encodeId=7d8791850e25, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=73, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210518/cd5ae48bc99d4e5b99357ba20b7ae160/700da5bab6de47cba94dcc7b36f23639.jpg, createdBy=f1831296933, createdName=ltxdsr810920, createdTime=Wed Jan 20 20:37:01 CST 2021, time=2021-01-20, status=1, ipAttribution=)]
    2021-01-20 ltxdsr810920

    学习了

    0

相关资讯

Neurology:肿瘤脑转移患者,可考虑使用当癫痫药物降低癫痫发作风险

肿瘤脑转移患者,可考虑使用当癫痫药物降低癫痫发作风险

新型抗肿瘤药物临床应用指导原则(2020年版),覆盖9大癌肿、83种药物

为进一步规范新型抗肿瘤药物临床应用,提高肿瘤合理用药水平,保障医疗质量和医疗安全,维护肿瘤患者健康权益,2020年12月29日,国家卫生健康委发布了《新型抗肿瘤药物临床应用指导原则(2020年版)》。

国家卫健委发布《抗肿瘤药物临床应用管理办法(试行)》

该《办法》共五章48条,对医疗机构内抗肿瘤药物的遴选、采购、储存、处方、调配、临床应用和药物评价等,进行全过程管理。针对当前肿瘤用药实际,主要突出了以下特点:

J Exp Med:脂质代谢与肿瘤发生发展的相互关系

该论文全面总结了肿瘤细胞脂质代谢调节的研究进展,并介绍了已被临床用于干扰脂质代谢的肿瘤治疗新方法,同时基于现有研究成果对该领域的未来发展趋势作了深入的讨论与分析。

Clin Trans Gastroenterology: 肿瘤细胞中再生肝磷酸酶3(PRL-3)的状态的可能是评估结直肠癌术后患者复发或转移的重要预后标志物

大肠癌(CRC)最常见的转移靶器官是肝脏。CRC患者初诊时发现约15%–20%的CRC患者有肝转移,其余60%的患者在随后的治疗中也有肝转移。

Science Immunology:细胞自噬的黑暗面,帮助癌细胞逃脱免疫系统杀伤

肿瘤免疫治疗的兴起,为人类彻底攻克“万病之王”——癌症带来了新的曙光。其中,免疫检查点阻断疗法已成为当今最热门的免疫疗法之一。